HBChE-IN-2

HBChE-IN-2 (compound 15d) is a butyrylcholinesterase (BChE) inhibitor (IC50 of 0.62 μM) and a cannabinoid receptor 2 (CB2R) agonist. hBChE-IN-2 has neuroprotection activities[1].

Product Specifications

CAS Number

[2923366-36-1]

UNSPSC

12352005

Target

Cannabinoid Receptor; Cholinesterase (ChE)

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/hbche-in-2.html

Solubility

10 mM in DMSO

Smiles

O=C(N(C)C)OC1=CC=C(CC2=NC3=C(N2CCC(C)C)C=CC(C(N(CC)CC)=O)=C3)C=C1

Molecular Formula

C27H36N4O3

Molecular Weight

464.60

References & Citations

[1]Philipp Spatz, et al. Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model. J Med Chem. 2023 May 11;66 (9) :6414-6435.